RecallDepth
Class II Ongoing

Decitabine for Injection 50mg per vial, For intravenous infusion only Cytotoxic Agent, Sterile, Rx Only, Single-Dose Vial, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 47335-361-40.

Company
Sun Pharmaceutical Industries Inc
Recall Initiated
July 2, 2024
Posted
July 10, 2024
Recall Number
D-0582-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
2088 vials
Firm Location
Princeton, NJ, United States

Reason for Recall

CGMP Deviations: Out of Specification for Total Aerobic Microbial Count (TAMC) test for unfiltered bulk for decitabine for injection.

Distribution

Nationwide in the USA

Lot / Code Info

HAD2964A, Exp 7/31/2024

More recalls by Sun Pharmaceutical Industries Inc

View all recalls by this company →

Other recent Class II Drug recalls